Lower 25-hydroxyvitamin D levels associated with adverse pathology in radical prostatectomy

26 Feb 2016


For men with localised prostate cancer undergoing radical prostatectomy, serum 25-hydroxyvitamin D insufficiency/deficiency is associated with increased odds of adverse pathology, according to research published in the Journal of Clinical Oncology.

Endocrinology Advisor


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story